Anavex Life Sciences
@AnavexLifeSci
A clinical stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodevelopmental and neurodegenerative diseases
ID:2707283114
http://anavex.com/ 04-08-2014 19:34:16
590 Tweets
1,9K Followers
180 Following
Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
anavex.com/post/anavex-li…
#Anavex #Biopharma #neuroscience #precisionmedicine
The accumulation of 'junk proteins' has been identified as one cause of aging.
SIGMAR1, which is activated by ANAVEX compounds, has been demonstrated to reduce accumulation of junk proteins.
#anavex #Biopharma #neuroscience #precisionmedicine
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
#anavex #biopharma #neuroscience #precisionmedicine
anavex.com/post/anavex-li…
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
#anavex #biopharma #neuroscience #precisionmedicine
anavex.com/post/anavex-li…
Anavex Life Sciences presents at the 44th Annual TD Cowen Health Care Conference
wsw.com/webcast/cowen1…
#anavex #biopharma #neuroscience #precisionmedicine
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
#anavex #biopharma #neuroscience #precisionmedicine
anavex.com/post/anavex-li…
Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
anavex.com/post/anavex-li…
#anavex #biopharma #neuroscience #precisionmedicine
Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
#anavex #biopharma #neuroscience #precisionmedicine
anavex.com/post/anavex-li…
Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans
#anavex #biopharma #neuroscience #precisionmedicine
anavex.com/post/anavex-li…
Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
anavex.com/post/anavex-li…
#anavex #biopharma #neuroscience #precisionmedicine
Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental Disorders
anavex.com/post/anavex-li…
#anavex #biopharma #neuroscience #precisionmedicine
The 42nd Annual Healthcare Conference hosted by J.P. Morgan in San Francisco serves as a pivotal force for transformation. We are enthusiastic about presenting at #JPM2024 and embarking on this journey into the new year!
#anavex #biopharma #neuroscience #precisionmedicine
Anavex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
anavex.com/post/anavex-to…
#anavex #biopharma #neuroscience #precisionmedicine
Special thanks to the Rett Syndrome Association of Australia Inc (RSAA) for their partnership. It is an honor to support the raising of awareness of the real world #livedexperiences of #rettsyndrome patient and families.
facebook.com/share/v/5BQpQ8…
#rettsyndrome #raredisease
Special thanks to the Rett Syndrome Association of Australia Inc (RSAA) for their partnership. Here are some accounts of #livedexperiences from #Patientstories currently enrolled in the ANAVEX2-73 compassionate use program
facebook.com/rettaustralia/…
#rettsyndrome #rarediseases
Anavex Life Sciences Provides an Update on Rett Syndrome Program
mailchi.mp/anavexcorp/ana…
#anavex #biopharma #neuroscience #precisionmedicine #rettsyndrome
'Australia led the world charge of the Anavex2-73 Rett study. Here are some accounts of #livedexeperiences from #PatientStories currently on compassionate use of drug in Australia.' - #RettSyndrome Association of Australia Inc (RSAA)
facebook.com/share/v/PHNyvy…
#patientexperience
